Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 10, 2020

Primary Completion Date

June 28, 2022

Study Completion Date

January 31, 2023

Conditions
Vitiligo
Interventions
DEVICE

Control Intervention (UVB)

Targeted narrowband-UVB phototherapy in alignment with published Vitiligo Working Group recommendations.

DEVICE

Investigational Interventions (Ablative Laser Resurfacing + RECELL + UVB)

Spray-On Skin™ Cells prepared using RECELL will be applied to an area prepared by ablative laser, followed by targeted narrowband UVB phototherapy.

Trial Locations (12)

28207

Dermatology, Laser & Vein Specialists of the Carolinas, Charlotte

29425

Medical University of South Carolina, Charleston

33021

Skin Care Research, LLC, Hollywood

33173

Miami Dermatology and Laser Institute, Miami

48202

Henry Ford Health System, Detroit

77008

Heights Dermatology, Houston

78712

University of Texas at Austin Dell Medical School, Austin

92121

West Dermatology, San Diego

92697

University of California, Irvine, Irvine

95817

University of California, Davis, Sacramento

06880

DMR Research, Westport

01581

University of Massachusetts, Worcester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Avita Medical

INDUSTRY